PainReform Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About PainReform Ltd
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy PainReform Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for PainReform Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for PainReform Ltd is PRFX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
PainReform Ltd has its primary listing on NASDAQ (Small cap). You can trade PainReform Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, PainReform Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include PainReform Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like PainReform Ltd.